You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Isoniazid

Showing 26 - 50 of 393
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis Trial in Worldwide (Rifapentine (RPT), Isoniazid (INH), Pyridoxine (vitamin B6))

Completed
Has Results
  • Tuberculosis
  • Rifapentine (RPT)
  • +2 more
  • Port-au-Prince, Haiti
  • +4 more
Nov 2, 2021

Tuberculosis Trial in Seattle (BCG Vaccine USP, Isoniazid)

Active, not recruiting
  • Tuberculosis
  • BCG Vaccine USP
  • Isoniazid
  • Seattle, Washington
    Fred Hutchinson Cancer Center
Dec 9, 2022

Pulmonary Tuberculosis Trial in Cape Town (PA-824, Rifampin, Rifabutin)

Completed
  • Pulmonary Tuberculosis
  • Cape Town, South Africa
    University of Cape Town Lung Institute
May 18, 2022

HIV, Tuberculosis Trial in Worldwide (Isoniazid (INH), Placebo for isoniazid (INH))

Completed
Has Results
  • HIV Infections
  • Tuberculosis
  • Isoniazid (INH)
  • Placebo for isoniazid (INH)
  • Gaborone, Botswana
  • +12 more
Nov 3, 2021

Latent Tuberculosis, End Stage Renal Disease, Renal Transplant Candidate for Right Kidney Trial in New Brunswick (Rifapentine)

Not yet recruiting
  • Latent Tuberculosis
  • +3 more
  • New Brunswick, New Jersey
    Pinki J Bhatt
Jun 6, 2022

Latent Tuberculosis, Diabetes, Type 2 Trial in Copenhagen (Rifampicin 300 Mg Oral Capsule, Isoniazid 300 Mg ORAL TABLET)

Recruiting
  • Latent Tuberculosis
  • Diabetes Mellitus, Type 2
  • Rifampicin 300 Mg Oral Capsule
  • Isoniazid 300 Mg ORAL TABLET
  • Copenhagen, Denmark
    Herlev-Gentofte Hospital
Aug 3, 2022

Tuberculous Meningitis Trial in Chennai (High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg)

Not yet recruiting
  • Tuberculous Meningitis
  • High dose rifampicin (25mg/kg)
  • +8 more
  • Chennai, Tamil Nadu, India
    ICMR- National Institute for Research in Tuberculosis
Jun 15, 2023

Tuberculosis Infection Trial in Zurich (Nivaquine ® (Chloroquine))

Recruiting
  • Tuberculosis Infection
  • Nivaquine ® (Chloroquine)
  • Zurich, Switzerland
    Clinical Trial Center
Jun 28, 2022

HIV, Tuberculosis Trial in Dire Dawa, Harar (Combination intervention components, Isoniazid Prevention Therapy)

Completed
  • HIV
  • Tuberculosis
  • Combination intervention components
  • Isoniazid Prevention Therapy
  • Dire Dawa, Ethiopia
  • +9 more
Jul 12, 2021

or Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV

Not yet recruiting
  • Tuberculosis
  • Pulmonary
    • Kampala, Uganda
    • +3 more
    Jul 12, 2021

    Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and

    Not yet recruiting
    • Pulmonary Tuberculosis
    • Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
    • +3 more
    • (no location specified)
    Jul 25, 2023

    Severe Acute Malnutrition, HIV, Comorbidities and Coexisting Conditions Trial (drug, behavioral, dietary supplement, other)

    Not yet recruiting
    • Severe Acute Malnutrition
    • +3 more
    • (no location specified)
    Aug 8, 2023

    Arterial Leg Ulcer Trial in Copenhagen (Isoniazid 300 milligram, Placebo)

    Withdrawn
    • Arterial Leg Ulcer
    • Isoniazid 300 milligram
    • Placebo
    • Copenhagen, Denmark
      Bispebjerg Hospital
    Mar 17, 2021

    Pulmonary Tuberculosis, Body Weight Changes, Motor Activity Trial (Rifampicin, Isoniazid, Pyrazinamide)

    Completed
    Has Results
    • Pulmonary Tuberculosis
    • +2 more
    • (no location specified)
    May 23, 2022

    Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)

    Not yet recruiting
    • Tuberculosis, Pulmonary
    • HIV
    • Port-au-Prince, Haiti
    • +1 more
    Nov 11, 2022

    Tuberculosis Trial in Kisumu (Isoniazid)

    Completed
    Has Results
    • Tuberculosis
    • Isoniazid
    • Kisumu, Kenya
      Kisumu County Hospital
    May 15, 2021

    Tuberculosis Trial in Manaus, Rio De Janeiro (Rifapentine 600 mg and INH 300 mg, Rifapentine 900 mg and INH 900 mg)

    Recruiting
    • Tuberculosis
    • Rifapentine 600 mg and INH 300 mg
    • Rifapentine 900 mg and INH 900 mg
    • Manaus, AM, Brazil
    • +1 more
    Apr 14, 2022

    Tuberculosis, Pulmonary Trial in Linköping (rifampicin, pyrazinamide, HRZE)

    Recruiting
    • Tuberculosis, Pulmonary
    • Linköping, Sweden
      Linköping University Hospital
    Aug 19, 2021

    doTBal® in Tuberculosis: Conduction ofIntensive

    Completed
    • Tuberculosis
    • Rifampicin/ Isoniazid/ Pyrazinamide/ Ethambutol
    • Mexico City, Mexico
      Laboratorio Silanes, S.A. de C.V.
    Jun 1, 2021

    Disseminated Tuberculosis, HIV Trial in Cape Town (Rifampin, Levofloxacin, Rifampicin, Pyrazinamide, Ethambutol and Isoniazid)

    Recruiting
    • Disseminated Tuberculosis
    • HIV
    • Cape Town, Western Cape, South Africa
    • +1 more
    Mar 30, 2022

    Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection Trial in Johannesburg (Isoniazid, Rifampicin, Ethambutol)

    Recruiting
    • Tuberculosis
    • +2 more
    • Isoniazid
    • +4 more
    • Johannesburg, Gauteng, South Africa
      Tembisa Clinical Research Centre-The Aurum Institute
    Jun 8, 2022

    Pulmonary Tuberculosis Trial (GSK3036656, BTZ-043, Bedaquiline (B))

    Not yet recruiting
    • Pulmonary Tuberculosis
    • (no location specified)
    Oct 27, 2023

    Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis Trial in Worldwide (Sutezolid, Rifampicin, Isoniazid)

    Recruiting
    • Pulmonary Tuberculosis
    • Other Specified Pulmonary Tuberculosis
    • Lambaréné, Gabon
    • +7 more
    Apr 17, 2023

    Bioneer Accupower Q-RFIA PCR Kit Clinical Evaluation

    Recruiting
    • Tuberculosis, Multidrug-Resistant
      • Nairobi, Kenya
      • +2 more
      Mar 16, 2022

      Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis Trial in Cape Town (BTZ-043, Rifafour e-275®, Probe Drug

      Completed
      • Pulmonary Tuberculoses
      • Other Specified Pulmonary Tuberculosis
      • Cape Town, South Africa
      • +1 more
      Aug 9, 2022